Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.421.571.261.020.93

What is the latest Sales/Fixed Asset ratio of BAFNA PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of BAFNA PHARMACEUTICALS is 1.42 based on Mar2025 Standalone results.
Year Sales/Fixed Asset
Mar20251.42
Mar20241.57
Mar20231.26
Mar20221.02
Mar20210.93

How is Sales/Fixed Asset of BAFNA PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.42
-9.55
Mar2024 1.57
24.60
Mar2023 1.26
23.53
Mar2022 1.02
9.68
Mar2021 0.93 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹260.2 Cr -5.3% -1.1% 40.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr -0.5% 3.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,872.0 Cr 4.5% 10% 41.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹107,136.0 Cr -1.7% 1% -10.5% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-5.3%

-1.1%

40.2%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses